VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Revelation Biosciences, Inc. (REVB) Total Return Calculator with Dividends Reinvested

Revelation Biosciences, Inc.

Popular:

The total return for Revelation Biosciences, Inc. (REVB) stock is -97.07% over the past 12 months. So far it's down 68.62% this year. The 5-year total return is -100.00%, meaning $10,000 invested in REVB stock 5 years ago would be worth $0 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in REVB 1 year ago, it would be worth $293 today — you'd have lost $9,707.

With Dividends Reinvested$293-97.07%

Price Only (No DRIP)$293-97.07%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in REVB

1Y$293-$9,707 (-97.1%)-97.1% CAGR

3Y$2-$9,998 (-100.0%)-94.7% CAGR

5Y$0-$10,000 (-100.0%)-92.8% CAGR

10Y$0-$10,000 (-100.0%)-73.1% CAGR

15Y$0-$10,000 (-100.0%)-58.3% CAGR

20Y$0-$10,000 (-100.0%)-48.1% CAGR

30Y$0-$10,000 (-100.0%)-35.4% CAGR

Revelation Biosciences, Inc. did not pay dividends during this period. Total return = price return.

Loading REVB total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-68.62%	—	-68.62%	—	$3,138
1Y	-97.07%	-97.07%	-97.07%	—	$293
3Y	-99.98%	-94.65%	-99.98%	—	$2
5Y	-100.00%	-92.75%	-100.00%	—	$0
10Y	-100.00%	-73.08%	-100.00%	—	$0
15Y	-100.00%	-58.31%	-100.00%	—	$0
20Y	-100.00%	-48.11%	-100.00%	—	$0
30Y	-100.00%	-35.43%	-100.00%	—	$0

Risk & Highlights

Best Year+2.97%2020

Worst Year-97.46%2025

Max Drawdown-98.35%2025-05-12 → 2026-01-24

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-59.38%	-59.38%	—	+0.41%	-59.8pp
2025	-97.46%	-97.46%	—	+16.64%	-114.1pp
2024	-96.99%	-96.99%	—	+24.00%	-121.0pp
2023	-92.68%	-92.68%	—	+24.81%	-117.5pp
2022	-94.32%	-94.32%	—	-19.95%	-74.4pp

REVB underperformed the S&P 500 by 128.39pp over the past year (-97.07% vs +31.32%).

Loading summary...

REVB Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
REVBRevelation Biosciences, Inc.	$633,216	-12.1%	-68.6%	-97.1%	—	-100.0%	-100.0%	-100.0%
ADMAADMA Biologics, Inc.	$2.5B	+8.6%	-43.6%	-56.4%	—	+188.0%	+514.6%	+64.7%
AGENAgenus Inc.	$137M	+3.2%	+20.4%	+31.0%	—	-87.8%	-93.1%	-93.5%
IMVTImmunovant, Inc.	$5.8B	+15.2%	+10.7%	+107.2%	—	+48.4%	+73.9%	+188.1%
HALOHalozyme Therapeutics, Inc.	$7.8B	+5.2%	-5.6%	+11.7%	—	+119.1%	+39.1%	+598.4%
NVAXNovavax, Inc.	$1.5B	+17.4%	+31.3%	+54.2%	—	+25.6%	-94.6%	-89.8%
DYAIDyadic International, Inc.	$28M	-12.1%	-19.1%	-32.1%	—	-56.5%	-81.7%	-55.0%
IBRXImmunityBio, Inc.	$8.3B	+18.4%	+314.9%	+316.9%	—	+30.7%	-47.7%	+4.7%
NKTRNektar Therapeutics	$1.7B	+13.9%	+96.0%	+783.6%	—	+636.7%	-69.4%	-57.6%
CLDXCelldex Therapeutics, Inc.	$2.3B	+9.6%	+27.3%	+86.9%	—	+3.1%	+29.4%	-34.3%
VXRTVaxart, Inc.	$179M	+20.1%	+106.9%	+96.7%	—	-13.4%	-89.2%	-95.8%

Compare:REVB vs ADMA REVB vs AGEN REVB vs IMVT REVB vs ADMA vs AGEN

About REVB Dividend Returns

Revelation Biosciences, Inc. (REVB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of REVB over the past year?

Revelation Biosciences, Inc. (REVB) delivered a return of -97.07% over the past year. Since REVB does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in REVB be worth today?

A $10,000 investment in Revelation Biosciences, Inc. one year ago would be worth $293 today, representing a loss of $9,707.

Q3Does REVB pay dividends?

Revelation Biosciences, Inc. (REVB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For REVB, the total return equals the price-only return.

Q4Did REVB beat the S&P 500?

No, Revelation Biosciences, Inc. (REVB) underperformed the S&P 500 by 128.39 percentage points over the past year. REVB delivered a total return of -97.07%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed REVB by 128.39pp during this period.

Q5What is REVB's worst drawdown?

Revelation Biosciences, Inc. (REVB) experienced a maximum drawdown of -98.35% over the past year, declining from its peak on 2025-05-12 to its trough on 2026-01-24. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is REVB's long-term total return over 10, 20, or 30 years?

Here are Revelation Biosciences, Inc. (REVB)'s long-term returns with dividends reinvested. Over 10 years, the total return is -100.0% (-73.1% CAGR) — $10,000 would have grown to $0. Over 20 years: -100.0% total return (-48.1% CAGR) — $10,000 → $0. Over 30 years: -100.0% total return (-35.4% CAGR) — $10,000 → $0. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was REVB's best and worst year?

Revelation Biosciences, Inc.'s best calendar year was 2020 with a total return of 3.0%. Its worst year was 2025 with a total return of -97.5%. This range shows the volatility investors should expect — the difference between the best and worst year is 100.4 percentage points.